VIAF

Virtual International Authority File

Search

Leader 00000nz a2200037n 45 0
001 WKP|Q51073096 (VIAF cluster) (Authority/Source Record)
003 WKP
005 20241221010841.0
008 241221nneanz||abbn n and d
035 ‎‡a (WKP)Q51073096‏
024 ‎‡a 0000-0003-2623-094X‏ ‎‡2 orcid‏
024 ‎‡a 25960350600‏ ‎‡2 scopus‏
035 ‎‡a (OCoLC)Q51073096‏
100 0 ‎‡a স্টুয়ার্ট এম রবিনসন‏ ‎‡9 bn‏
400 0 ‎‡a Stuart M. Robinson‏ ‎‡c researcher‏ ‎‡9 en‏
400 0 ‎‡a Stuart M Robinson‏ ‎‡c wetenschapper‏ ‎‡9 nl‏
670 ‎‡a Author's An experimental study to identify the potential role of pharmacogenomics in determining the occurrence of oxaliplatin-induced liver injury.‏
670 ‎‡a Author's Chronic pancreatitis: Do serum biomarkers provide an association with an inflammageing phenotype?‏
670 ‎‡a Author's Hepatic sinusoidal obstruction syndrome reduces the effect of oxaliplatin in colorectal liver metastases‏
670 ‎‡a Author's Idiopathic pseudomembranous colitis limited to the right colon: a change from Clostridium difficile‏
670 ‎‡a Author's Immunotherapy for treating metastatic colorectal cancer.‏
670 ‎‡a Author's Laparoscopic liver resection: is there a learning curve?‏
670 ‎‡a Author's Laparoscopic Pringle's manoeuvre for liver resection?: how I do it‏
670 ‎‡a Author's Laparoscopic splenic biopsy--porcine to human studies--using a fibrin sealant technique‏
670 ‎‡a Author's Metastatic lymph node ratio as an important prognostic factor in pancreatic ductal adenocarcinoma‏
670 ‎‡a Author's Methods of haemostasis during liver resection--a UK national survey‏
670 ‎‡a Author's Pathogenesis of FOLFOX induced sinusoidal obstruction syndrome in a murine chemotherapy model.‏
670 ‎‡a Author's Role of nuclear factor kappaB in liver health and disease.‏
670 ‎‡a Author's Strategies to reduce pancreatic stump complications after open or laparoscopic distal pancreatectomy‏
670 ‎‡a Author's Surgical adjuncts to laparoscopic distal pancreatectomy‏
670 ‎‡a Author's The potential contribution of tumour-related factors to the development of FOLFOX-induced sinusoidal obstruction syndrome‏
670 ‎‡a Author's Use of Fibrin-Based Sealants and Gelatin-Matrix Hemostats in Laparoscopic Liver Surgery‏
670 ‎‡a Author's What to do for the incidental pancreatic cystic lesion?‏
909 ‎‡a (orcid) 000000032623094x‏ ‎‡9 1‏
909 ‎‡a (scopus) 25960350600‏ ‎‡9 1‏
919 ‎‡a idiopathicpseudomembranouscolitislimitedtotherightcolonachangefromclostridiumdifficile‏ ‎‡A Idiopathic pseudomembranous colitis limited to the right colon: a change from Clostridium difficile‏ ‎‡9 1‏
919 ‎‡a immunotherapyfortreatingmetastaticcolorectalcancer‏ ‎‡A Immunotherapy for treating metastatic colorectal cancer.‏ ‎‡9 1‏
919 ‎‡a laparoscopicliverresectionistherealearningcurve‏ ‎‡A Laparoscopic liver resection: is there a learning curve?‏ ‎‡9 1‏
919 ‎‡a laparoscopicpringlesmanoeuvreforliverresectionhow1doit‏ ‎‡A Laparoscopic Pringle's manoeuvre for liver resection?: how I do it‏ ‎‡9 1‏
919 ‎‡a whattodofortheincidentalpancreaticcysticlesion‏ ‎‡A What to do for the incidental pancreatic cystic lesion?‏ ‎‡9 1‏
919 ‎‡a useoffibrinbasedsealantsandgelatinmatrixhemostatsinlaparoscopicliversurgery‏ ‎‡A Use of Fibrin-Based Sealants and Gelatin-Matrix Hemostats in Laparoscopic Liver Surgery‏ ‎‡9 1‏
919 ‎‡a potentialcontributionoftumourrelatedfactorstothedevelopmentoffolfoxinducedsinusoidalobstructionsyndrome‏ ‎‡A The potential contribution of tumour-related factors to the development of FOLFOX-induced sinusoidal obstruction syndrome‏ ‎‡9 1‏
919 ‎‡a surgicaladjunctstolaparoscopicdistalpancreatectomy‏ ‎‡A Surgical adjuncts to laparoscopic distal pancreatectomy‏ ‎‡9 1‏
919 ‎‡a strategiestoreducepancreaticstumpcomplicationsafteropenorlaparoscopicdistalpancreatectomy‏ ‎‡A Strategies to reduce pancreatic stump complications after open or laparoscopic distal pancreatectomy‏ ‎‡9 1‏
919 ‎‡a roleofnuclearfactorkappabinliverhealthanddisease‏ ‎‡A Role of nuclear factor kappaB in liver health and disease.‏ ‎‡9 1‏
919 ‎‡a pathogenesisoffolfoxinducedsinusoidalobstructionsyndromeinamurinechemotherapymodel‏ ‎‡A Pathogenesis of FOLFOX induced sinusoidal obstruction syndrome in a murine chemotherapy model.‏ ‎‡9 1‏
919 ‎‡a methodsofhaemostasisduringliverresectionauknationalsurvey‏ ‎‡A Methods of haemostasis during liver resection--a UK national survey‏ ‎‡9 1‏
919 ‎‡a metastaticlymphnoderatioasanimportantprognosticfactorinpancreaticductaladenocarcinoma‏ ‎‡A Metastatic lymph node ratio as an important prognostic factor in pancreatic ductal adenocarcinoma‏ ‎‡9 1‏
919 ‎‡a laparoscopicsplenicbiopsyporcinetohumanstudiesusingafibrinsealanttechnique‏ ‎‡A Laparoscopic splenic biopsy--porcine to human studies--using a fibrin sealant technique‏ ‎‡9 1‏
919 ‎‡a experimentalstudytoidentifythepotentialroleofpharmacogenomicsindeterminingtheoccurrenceofoxaliplatininducedliverinjury‏ ‎‡A An experimental study to identify the potential role of pharmacogenomics in determining the occurrence of oxaliplatin-induced liver injury.‏ ‎‡9 1‏
919 ‎‡a chronicpancreatitisdoserumbiomarkersprovideanassociationwithaninflammageingphenotype‏ ‎‡A Chronic pancreatitis: Do serum biomarkers provide an association with an inflammageing phenotype?‏ ‎‡9 1‏
919 ‎‡a hepaticsinusoidalobstructionsyndromereducestheeffectofoxaliplatinincolorectallivermetastases‏ ‎‡A Hepatic sinusoidal obstruction syndrome reduces the effect of oxaliplatin in colorectal liver metastases‏ ‎‡9 1‏
996 ‎‡2 KRNLK|KAC200814061
996 ‎‡2 NUKAT|n 2010179133
996 ‎‡2 CAOONL|ncf10144574
996 ‎‡2 LC|nr 98015244
996 ‎‡2 J9U|987007459821105171
996 ‎‡2 CAOONL|ncf11340653
996 ‎‡2 BIBSYS|9028521
996 ‎‡2 ISNI|0000000063307115
996 ‎‡2 NII|DA08198943
996 ‎‡2 CAOONL|ncf10021106
996 ‎‡2 ISNI|0000000073949349
996 ‎‡2 ISNI|0000000384863315
996 ‎‡2 J9U|987007275795805171
996 ‎‡2 NKC|jx20110420012
996 ‎‡2 PLWABN|9810638931005606
996 ‎‡2 LC|no 99040262
996 ‎‡2 LC|n 82259111
996 ‎‡2 BNF|12493002
996 ‎‡2 J9U|987007320532405171
996 ‎‡2 ISNI|0000000373815895
996 ‎‡2 SUDOC|189430656
996 ‎‡2 NLA|000035626389
996 ‎‡2 LC|n 94048388
996 ‎‡2 LC|nr2002045166
996 ‎‡2 LC|n 86866668
996 ‎‡2 NII|DA10568604
996 ‎‡2 NTA|074224549
996 ‎‡2 LC|n 2005046495
996 ‎‡2 NUKAT|n 2016154828
996 ‎‡2 ISNI|000000005259442X
996 ‎‡2 LC|n 88274884
996 ‎‡2 LC|no2021034697
996 ‎‡2 RERO|A012314658
996 ‎‡2 LC|n 94117300
996 ‎‡2 CAOONL|ncf10033359
996 ‎‡2 SUDOC|196212650
996 ‎‡2 LC|n 2006164033
996 ‎‡2 RERO|A017986722
996 ‎‡2 NTA|172390834
996 ‎‡2 NTA|227521226
996 ‎‡2 CAOONL|ncf11576026
996 ‎‡2 ISNI|0000000067842529
996 ‎‡2 ISNI|0000000046628291
996 ‎‡2 BIBSYS|3101242
996 ‎‡2 LC|n 50046570
996 ‎‡2 NLA|000035690350
996 ‎‡2 SUDOC|274105950
996 ‎‡2 NLA|000035079869
996 ‎‡2 LC|n 2007041092
996 ‎‡2 ISNI|0000000037043988
996 ‎‡2 LC|no2009004108
996 ‎‡2 NSK|000358650
996 ‎‡2 NTA|332994090
996 ‎‡2 J9U|987007453669805171
996 ‎‡2 LC|no2012062623
996 ‎‡2 BIBSYS|2098987
996 ‎‡2 LC|no2024107665
996 ‎‡2 LC|nb2010033277
996 ‎‡2 DNB|1089327668
996 ‎‡2 LC|n 88274885
996 ‎‡2 BAV|495_249467
996 ‎‡2 ISNI|0000000391676438
996 ‎‡2 NLA|000035351882
996 ‎‡2 LC|n 2002066957
996 ‎‡2 LC|no 96059563
996 ‎‡2 BIBSYS|90985538
996 ‎‡2 NII|DA01314321
996 ‎‡2 SUDOC|165815310
996 ‎‡2 LC|no2003027958
996 ‎‡2 RERO|A003752283
996 ‎‡2 LC|no2012086770
996 ‎‡2 BIBSYS|90222950
996 ‎‡2 ISNI|0000000036715287
996 ‎‡2 ISNI|0000000120330339
996 ‎‡2 NTA|25657989X
996 ‎‡2 NLA|000035064336
996 ‎‡2 ISNI|0000000023554306
997 ‎‡a 0 0 lived 0 0‏ ‎‡9 1‏